ArticleThrombosis journal2026

The complement factor B inhibitor iptacopan for relapsed and refractory immune thrombotic thrombocytopenic purpura.

Minran Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.